BOCH
RLYB icon

Blue Owl Capital Holdings’s Rallybio RLYB Stock Holding History

Blue Owl Capital Holdings’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-43,780
Closed -$648K – 52
2024
Q1 		$648K Hold
43,780
– – 0.13% 40
2023
Q4 		$837K Buy
+43,780
New +$1.07M 0.2% 35

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blue Owl Capital Holdings's RLYB Position: Q2 2024 in Review

Blue Owl Capital Holdings sold out of Rallybio (RLYB) in Q2 2024, closing a stake of 43,780 shares — an estimated $648K sold.

Blue Owl Capital Holdings first reported a position in RLYB in Q4 2023 and held it in 2 quarters. The position peaked at $837K in Q4 2023. 66 funds tracked by Wall St. Rank hold RLYB as of Q2 2024.

  • Blue Owl Capital Holdings reported no remaining Rallybio position as of Q2 2024 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 43,780 Rallybio shares in Q2 2024, an estimated $648K.
  • Blue Owl Capital Holdings first reported a position in Rallybio in Q4 2023 and held it in 2 quarters.
  • Blue Owl Capital Holdings's Rallybio position peaked at $837K in Q4 2023.
  • 66 funds tracked by Wall St. Rank held Rallybio as of Q2 2024.

Based on Blue Owl Capital Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.